OPKO Health Number of Employees 2010-2025 | OPK

OPKO Health number of employees from 2010 to 2025. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis
OPKO Health Annual Employee Count
2024 2,997
2023 3,930
2022 4,196
2021 5,767
2020 5,269
2019 6,096
2018 5,690
2017 6,030
2016 6,041
2015 5,936
2014 674
2013 625
2012 549
2011 268
2010 220
2009 95
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.094B $0.713B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $197.793B 86.63
Thermo Fisher Scientific (TMO) United States $150.971B 18.26
Edwards Lifesciences (EW) United States $45.591B 29.89
IDEXX Laboratories (IDXX) United States $42.288B 48.60
Alcon (ALC) Switzerland $42.138B 28.48
DexCom (DXCM) United States $34.031B 52.60
IQVIA Holdings (IQV) United States $24.701B 13.84
Mettler-Toledo (MTD) United States $24.242B 28.83
STERIS (STE) Ireland $23.937B 26.36
Waters (WAT) United States $20.792B 29.34
SONOVA HOLDING (SONVY) Switzerland $18.231B 0.00
Hologic (HOLX) United States $14.048B 15.26
Sysmex ADR (SSMXY) Japan $10.336B 29.32
Penumbra (PEN) United States $9.967B 78.22
Masimo (MASI) United States $8.883B 32.77
Globus Medical (GMED) United States $8.082B 19.26
Glaukos (GKOS) United States $5.399B 0.00
Teleflex (TFX) United States $5.366B 8.86
TransMedics (TMDX) United States $4.355B 94.66
Integer Holdings (ITGR) United States $4.182B 21.91
PROCEPT BioRobotics (PRCT) United States $3.319B 0.00
LivaNova (LIVN) United Kingdom $2.405B 14.32
Veracyte (VCYT) United States $2.075B 29.12
Nihon Kohden (NHNKY) Japan $2.022B 23.20
Elekta AB (EKTAY) Sweden $1.956B 17.59
Alphatec Holdings (ATEC) United States $1.851B 0.00
Tandem Diabetes Care (TNDM) United States $1.374B 0.00
Artivion (AORT) United States $1.215B 113.80
Pulse Biosciences (PLSE) United States $1.186B 0.00
Integra LifeSciences Holdings (IART) United States $1.013B 5.39
SiBone (SIBN) United States $0.805B 0.00
Beta Bionics (BBNX) United States $0.779B 0.00
IRadimed (IRMD) United States $0.760B 38.57
RxSight (RXST) United States $0.642B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.576B 8.96
Delcath Systems (DCTH) United States $0.560B 0.00
Mesa Laboratories (MLAB) United States $0.546B 12.80
AxoGen (AXGN) United States $0.517B 0.00
OrthoPediatrics (KIDS) United States $0.496B 0.00
AngioDynamics (ANGO) United States $0.445B 0.00
NeuroPace (NPCE) United States $0.444B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.432B 0.00
Semler Scientific (SMLR) United States $0.397B 10.56
Treace Medical Concepts (TMCI) United States $0.365B 0.00
ClearPoint Neuro (CLPT) United States $0.354B 0.00
Pacific Biosciences Of California (PACB) United States $0.315B 0.00
Neuronetics (STIM) United States $0.254B 0.00
Tactile Systems Technology (TCMD) United States $0.239B 14.48
908 Devices (MASS) United States $0.237B 0.00
Alpha Tau Medical (DRTS) Israel $0.211B 0.00
Sight Sciences (SGHT) United States $0.208B 0.00
CVRx (CVRX) United States $0.176B 0.00
Biosig Technologies (BSGM) United States $0.175B 0.00
Inogen (INGN) United States $0.172B 0.00
Spectral Diagnostics (EDTXF) Canada $0.171B 0.00
Rapid Micro Biosystems (RPID) United States $0.163B 0.00
Accuray (ARAY) United States $0.162B 0.00
Anteris Technologies Global (AVR) Australia $0.161B 0.00
LENSAR (LNSR) United States $0.160B 0.00
Lucid Diagnostics (LUCD) United States $0.136B 0.00
Atossa Genetics (ATOS) United States $0.110B 0.00
Microbot Medical (MBOT) United States $0.099B 0.00
Monogram Orthopaedics (MGRM) United States $0.087B 0.00
Sensus Healthcare (SRTS) United States $0.079B 48.30
InspireMD (NSPR) United States $0.078B 0.00
EDAP TMS S.A (EDAP) France $0.067B 0.00
EnVVeno Medical (NVNO) United States $0.061B 0.00
Hyperfine (HYPR) United States $0.058B 0.00
Positron (POSC) United States $0.054B 0.00
Spectral AI (MDAI) United States $0.044B 0.00
Vicarious Surgical (RBOT) United States $0.043B 0.00
Precision Optics (POCI) United States $0.034B 0.00
Envoy Medical (COCH) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.030B 0.00
Baird Medical Investment Holdings (BDMD) $0.028B 0.00
Adagio Medical Holdings (ADGM) United States $0.018B 0.00
NexGel (NXGL) United States $0.017B 0.00
WORK Medical Technology Group (WOK) China $0.012B 0.00
Ekso Bionics Holdings (EKSO) United States $0.010B 0.00
PAVmed (PAVM) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
ReShape Lifesciences (RSLS) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Nuwellis (NUWE) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Avinger (AVGR) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.001B 0.00
Accelerate Diagnostics (AXDX) United States $0.001B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.19
Longview Acquisition II (LGV) United States $0.000B 0.00